China Top Paclitaxel Eluting Balloon Manufacturers

Advanced Vascular Interventional Solutions for Global Healthcare Excellence

The Global Landscape of Paclitaxel Eluting Balloons (PEB)

The global medical community has witnessed a paradigm shift in vascular intervention with the rise of Paclitaxel Eluting Balloons (PEB), also known as Drug-Coated Balloons (DCB). As a cornerstone of the "leave nothing behind" philosophy, PEBs offer a sophisticated alternative to traditional stenting. By delivering an anti-proliferative drug directly to the vessel wall, these devices inhibit neointimal hyperplasia—the primary cause of restenosis—without the need for a permanent metallic implant.

Market Insight: The global Paclitaxel Eluting Balloon market is projected to grow at a CAGR of over 8% through 2030, driven by the increasing prevalence of peripheral artery disease (PAD) and the clinical success in treating small-vessel coronary artery disease.

Industry leaders and healthcare providers are increasingly prioritizing PEBs for complex clinical scenarios, such as In-Stent Restenosis (ISR) and Critical Limb Ischemia (CLI). The demand is particularly high in regions like Europe and the Asia-Pacific, where clinical guidelines have integrated DCB therapy as a primary recommendation for femoropopliteal interventions.

🔬

Technological Precision

Modern PEBs utilize proprietary excipients to ensure stable drug coating and optimal transfer efficiency during balloon inflation, reducing drug loss during navigation.

📈

Clinical Trends

The "Stent-less" approach is gaining momentum globally, significantly reducing long-term complications such as late stent thrombosis and inflammatory responses.

🌐

Procurement Demand

Global hospitals and distributors are seeking high-quality, CE-certified manufacturers in China to bridge the gap between high-performance clinical needs and cost-effective procurement.

SJ Medical: Innovation in Every Micron

Hangzhou SJ Medical Co., Ltd., established in 2015, stands at the forefront of China's vascular interventional medical device industry. We are dedicated to the research, development, and manufacturing of high-end therapeutic solutions, specializing in both cardiovascular and peripheral interventions. Our commitment is to provide safe, reliable, and innovative tools that empower healthcare providers globally.

5000+

Sqm Facility

10+

Global Markets

ISO

Certified Quality

CE

Approval

Our product portfolio is a testament to our R&D prowess. From precision-engineered PTCA balloon catheters to advanced Drug-Eluting Stent (DES) systems, SJ Medical integrates interventional access, diagnostic, and therapeutic devices into a cohesive medical ecosystem. Our focus on Paclitaxel Eluting Balloons leverages advanced coating technology to ensure uniform drug delivery and superior clinical outcomes.

SJ Medical Facility

State-of-the-Art Manufacturing & GMP Standards

At SJ Medical, quality is not a department; it is a philosophy. Our 5,000-square-meter modern manufacturing facility is built to rigorous GMP standards. We operate high-standard cleanrooms, including localized hundred-class areas for critical drug-coating and assembly processes, ensuring the highest level of product sterility and integrity.

⚙️

Precision Equipment

Utilizing laser welding, marking technologies, and high-accuracy balloon forming equipment to guarantee consistency.

🛡️

Strict Quality Control

Comprehensive laboratory testing facilities monitor every stage of production, from raw material to final sterile packaging.

👨‍🔬

Expert Engineering

Led by senior industry veterans with decades of experience in interventional medical device design and manufacturing.

Clinical Applications & Global Compliance

Our vascular interventional devices are designed for a wide array of clinical scenarios, including coronary artery disease (CAD), renal artery stenosis, and peripheral vascular occlusions. By improving procedural efficiency and patient safety, SJ Medical's products help reduce recovery times and enhance long-term patient outcomes.

📜 Certified Reliability: We maintain CE certification, ISO 13485, and CFDA (NMPA) approvals. This regulatory excellence allows us to support healthcare systems in Finland, Italy, Spain, India, Indonesia, and beyond.
Global Service

Company Profile Detail

SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.

Our Factory Infrastructure

SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.

Global Market Reach

SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt, among others.

Our Commitment to Service

SJ Medical is committed to providing comprehensive and professional services throughout the entire customer journey. From pre-sales consultation and technical support to efficient order processing and responsive after-sales service, the company ensures that every customer receives timely assistance and reliable solutions.